The influence of the immunosuppressants OKT3 and ATG on immunological parameters

Clinical Nephrology

Volumn 45, Issue 5, 1996, Pages 345-348

  Neumann, M Ch ^a   Muller T F ^a   Sprenger, H ^b   Gemsa, D ^b   Lange, H ^a,b  

^a Center of Internal Medicine   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Acute rejection; Antibody therapy; Immune mediators; Transplantation

Indexed keywords

AMYLOID A PROTEIN; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; MONOCLONAL ANTIBODY; NEOPTERIN; OKT 3; POLYCLONAL ANTIBODY; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; BODY TEMPERATURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GRAFT REJECTION; HUMAN; IMMUNE SYSTEM; ORGAN TRANSPLANTATION; URINE LEVEL;

ACUTE DISEASE; ANTILYMPHOCYTE SERUM; CYTOKINES; GRAFT REJECTION; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; MUROMONAB-CD3;

EID: 0029935717     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Abramowicz D, Schandene L, Goldman M, Crusiaux A, Vereerstraeten P, De Pauw L, Wybran J, Kinnaert P, Dupant E, Toussaint C 1989 Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 47: 606-608
2. Auchincloss H, Sachs DH 1989 Transplantation and graft rejection. In: Paul WE (ed) Fundamental Immunology, 2nd Edn. Raven Press, New York; pp 889-922
3. Attallah AM, Abdelghaffar H, Alghraoui F, Fawzy A, Alijani MR, Mahmoud LA, Ghoneim MA, Helfrich GB 1987 Immunological monitonng and early prediction of rejection in renal allograft recipients. Int Archs Allergy Appl Immun 84: 10-17
4. Beutler B, Cerami A 1987 Cachectin: More than a tumor necrosis factor. New Engl J Med 316: 379-385
5. Chatenoud L, Ferran C, Legendre C, Thouard I, Merite S, Reuter A, Gevaert Y, Kreis H, Franchimont P, Bach JF 1990 In vivo cell activation following OKT3 administation. Transplantation 49: 697-702
6. Colvin RB, Preffer FI, Fuller T, Brown M, Ip S, Kung P, Cosimi AB 1989 A critical analysis of serum and urine interleukin 2 receptor assays in renal allograft recipients. Transplant Proc 21: 1863
7. Debets JMH, Leunissen KML, van Hooff HJ, van der Linden CJ, Buurman WA 1989 Evidence of involvement of tumor necrosis factor in adverse reactions during treatment of kidney allograft rejection with antithymocyte globulin. Transplantation 47: 487-492
8. McLaughlin PJ, Aikawa AA, Davies HM, Ward RG, Bakran A, Sells RA, Johnson PM 1991 Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients. Transplantation 51: 1225-1229
9. van der Meer JWM, Endres S, Lonnemann G, Canon JG, Ikejima T, Okusawa S, Gelfand JA, Dinarello CA 1988 Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leukoc Biol 43: 216-223
10. Müller Th, Sprenger H, Neumann Ch, Keuchel M, Gemsa D, Lange H 1991 a Kritische Analyse der Messungen von Serum Amyloid A, Neopterin und Cytokinen bei Nierentransplantation. Klin Wochenschr 69 (Suppl 23): 243
11. Müller Th, Sprenger H, Keuchel M, Neumann Ch, Ebel H, Feiber H, Gemsa D, Lange H 1991b Cytokines in the monitoring of kidney transplantation. In: Abstracts of the International Symposium on Transplant Monitoring, Jerusalem 1991
12. Muller Th, Schindler S, Sprenger H, Steinmetz A, Hocke G, Ebel H, Gemsa D, Lange H 1992 Prospective analysis of 10 different parameters of acute renal allograft rejection. Transplant Proc 24: 2731-2734
13. Noronha IL, Daniel V, Rambausek M, Waldherr R, Opelz G 1990 Soluble interleukin-2 receptor (sIL-2R) and tumor necrosis factor plasma levels in renal allograft recipients. Transplant Proc 22: 1859-1860
14. Ramadori G, Van Damme J, Rieder H, Meyer zum Büschenfelde KH 1988 Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1β and tumor necrosis factor-α. Eur J Immunol 18: 1259-1264
15. Reibnegger G, Aichberger C, Fuchs D, Hausen A, Spielberger M, Werner ER, Margreiter R, Wachter H 1991 Posttransplant neopterin excretion in renal allograft recipients - A reliable diagnostic aid for acute rejection and allograft recipients - A reliable diagnositc aid for acute rejection and predictive marker of longerm graft survival. Transplantation 52: 58-63
16. Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL 1985 Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135: 3172-3177
17. Sipe JD, Johns MA, Ghezzi P, Knapschaefer G 1988 Modulation of serum amyloid A gene expression by cytokines and bacterial cell wall components Adv Exp Med Biol 243: 193-201
18. White DJG, Obers A 1990 Tumour necrosis factor in organ transplantation. Ann Acad Med 19: 142-146
19. Yoshimura N, Oka T, Kahan BD 1991 Sequential determination of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients. Transplantation 51 (1): 172-176